Reportlinker.com announces that a new market research report is available in its catalogue.
Rx to OTC Switches 2009
http://www.reportlinker.com/p0116163/Rx-to-OTC-Switches-2009.html
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products.
The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.
All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.
As part of its coverage, this report includes
- Current Market for Rx to OTC across major categories
- Past Results of OTC Switches
- Products Most Likely to Switch to OTC
- Assessment of the Economic Downturn's Impact
The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:
- Allergy, Cough, Cold, and Sinus Products
- Analgesics, NSAIDs, and Pain Treatments
In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include: